Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,210 | -8,846 | -4,270 | -2,140 | -6,000 |
| Depreciation Amortization | 50 | 84 | 59 | 18 | -2,500 |
| Accounts payable and accrued liabilities | 1,134 | -14 | 316 | 484 | N/A |
| Other Working Capital | 930 | 226 | 489 | 699 | 510 |
| Other Operating Activity | 2,666 | 3,362 | 140 | -220 | 3,400 |
| Operating Cash Flow | $-7,430 | $-5,188 | $-3,266 | $-1,159 | $-4,590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -16 | -12 | -10 | 0 |
| Investing Cash Flow | $-20 | $-16 | $-12 | $-10 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,383 | 7,383 | 7,283 | 255 | N/A |
| Debt Repayment | -42 | -42 | -42 | N/A | N/A |
| Common Stock Issued | 45,549 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -20 | -134 | -167 | -13 | 5,120 |
| Financing Cash Flow | $52,870 | $7,207 | $7,074 | $242 | $5,120 |
| Beginning Cash Position | 2,610 | 2,618 | 2,618 | 2,618 | 2,080 |
| End Cash Position | 48,030 | 4,621 | 6,414 | 1,690 | 2,610 |
| Net Cash Flow | $45,410 | $2,003 | $3,797 | $-927 | $520 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,430 | -5,188 | -3,266 | -1,159 | -4,590 |
| Capital Expenditure | -20 | -16 | -12 | -10 | N/A |
| Free Cash Flow | -7,450 | -5,204 | -3,277 | -1,169 | -4,590 |